Latest Interviews
Showing 1–3 of 3 transcripts.
Clear all filters- Milken Institute51 min
Innovation in Artificial Intelligence and Manufacturing | Middle East & Africa Summit 2025
Hunny Bhagchandani, Kaushik Burman, Frans Cronje, Songo Didiza, Guy Diedrich, Mostafa El-Ghorab, Kweilin Ellingrud, John Kamara, Francis Kariuki, Ayaan Mohamed, Editha Mshiu, Emily Musil, Nneile Nkholise, Derick Nwumfor Chunga, Michael Milken
Launched in 2021, the Milken-Mozzeppe Innovation Prize's fourth "AI and Manufacturing" track selected ten semi-finalists from over 12,000 global applicants to compete for a $1 million grand prize at the May 2026 Milken Institute Global Conference. A panel of industry experts evaluated these contenders based on commercial viability and technological depth, with five companies including Digitech Oasis and Blee Glee Management Company advancing to the final round while all ten recipients received $50,000 seed awards. Strategic commentary from leaders such as Michael Milken underscored the program's role in catalyzing local African manufacturing, creating youth jobs, and disintermediating global industries through AI-driven innovation.
- Milken Institute1h 11m
Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science (updated II)
Nancy Brown, Francis Collins, Thomas Frieden, Andrew von Eschenbach, Michael Milken, Mike Milken, Tom Frieden, Andy Van Eschenbach, Jack Andreyka
A comprehensive analysis of global bioscience reveals a dramatic increase in life expectancy and major breakthroughs in disease eradication, such as the near-elimination of polio and HIV management through programs like PEPFAR. Despite these successes, the sector faces a critical funding crisis where declining NIH grant success rates and inflation-adjusted budget cuts threaten the pipeline of young researchers and the translation of genetic discoveries into new treatments. Strategic initiatives like the Brain Initiative, precision medicine efforts, and the shift toward prevention are now essential to address rising chronic disease burdens and sustain the bioscience industry as a primary driver of US economic growth.
- Milken Institute1h 14m
Investing in African Prosperity
Tony Blair, Bill Gates, H.E. Paul Kagame, Strive Masiyiwa, Rhonda Zygocki, Michael Milken
Economic and health data reveal that twenty-five African nations have achieved middle-income status, driven by demographic dividends, rapid mobile adoption, and strategic investments from corporations like Chevron and the Agricultural Transformation Agency in Ethiopia. Successful interventions in countries such as Rwanda and Zimbabwe demonstrate that combining local capacity building with global partnerships can eliminate extreme poverty, eradicate diseases like polio, and transform sectors ranging from agriculture to financial services. These outcomes suggest a future where infrastructure leapfrogging and transparent governance create a sustainable win-win scenario for both private investors and African populations.